China Pharma Holdings Inc.

China Pharma Holdings Inc.

CPHI

Get informed when a big investor buys or sells

+ Follow
Market Cap$39.71M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
China Pharma Holdings Inc.China Pharma Holdings Inc.-1--18%--
$-0.44

Current Fair Value

150.9% downside

Overvalued by 150.9% based on the discounted cash flow analysis.

Share Statistics

Market cap$39.71 Million
Enterprise Value$-156,474,288,440.00
Dividend Yield$- (-)
Earnings per Share$-0.74
Beta1.07
Outstanding Shares4,291,000

Return

Return on Equity-17.80%ROE
Return on Assets-14.40%
Return on Invested Capital-20.05%

Valuation & Multiples

P/E Ratio-0.97P/E Ratio
PEG0PEG
Price to Sales0.0Price to Sales
Price to Book Ratio0.0Price to Book Ratio
Enterprise Value to Revenue-0.02
Enterprise Value to EBIT0.02
Enterprise Value to Net Income0
Total Debt to Enterprise-0.95
Debt to Equity0Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 14, 2026
EPS Estimate
-
Average shareholder expectation
Revenue Estimate
-
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %0.60%▼ 0.08%
Total Invested$15,719▼ 55.65%
Investors Holding6▲ 1.00%

ESG Score

No data

About China Pharma Holdings Inc.

CEO: Zhilin Li